- Home
- OPK
OPK
OPKO Health Inc.
as 12-20-2024 4:00pm EST
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 1.1B | IPO Year: | 1995 |
| Target Price: | $2.75 | AVG Volume (30 days): | 4.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $1.76 | Next Earning Date: | 11-07-2024 |
| Revenue: | $711,408,000 | Revenue Growth: | -17.94% |
| Revenue Growth (this year): | -19.61% | Revenue Growth (next year): | -0.19% |
Stock Insider Trading Activity of OPKO Health Inc. (OPK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Dec 13 '24 | Buy | $1.60 | 125,000 | $199,375.00 | 212,536,477 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Dec 11 '24 | Buy | $1.56 | 500,000 | $781,050.00 | 212,536,477 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 29 '24 | Buy | $1.53 | 199,072 | $305,376.45 | 212,536,477 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 22 '24 | Buy | $1.59 | 100,000 | $159,000.00 | 212,536,477 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 14 '24 | Buy | $1.62 | 100,000 | $161,980.00 | 212,536,477 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 8 '24 | Buy | $1.50 | 280,183 | $421,535.32 | 212,536,477 |
Latest OPKO Health Inc. News
OPK Breaking Stock News: Dive into OPK Ticker-Specific Updates for Smart Investing
Insider Monkey
11 days ago
Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?
PR Newswire
12 days ago
NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer
Simply Wall St.
14 days ago
OPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years ago
Barrons.com
23 days ago
Sleep Number, Getty Images, and More Stocks See Action From Activist Investors
GlobeNewswire
a month ago
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
PR Newswire
a month ago
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
Barrons.com
a month ago
Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
PR Newswire
a month ago
NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results
Compare OPK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPK OPKO Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.